Month: July 2021

Not for distribution to U.S. news wire services or dissemination in the United States TORONTO, July 12, 2021 (GLOBE NEWSWIRE) — Signature Resources Ltd. (TSXV: SGU, OTCQB: SGGTF, FSE 3S3) (“Signature” or the “Company”) is pleased to announce that, further to its press release dated June 21, 2021, it has closed an oversubscribed non-brokered private placement (the “Offering”) effective July 9, 2021 by issuing 13,107,312 non-flow-through units (the “NFT Units”) and 10,965,591 flow-through units (the ”FT Units”) for aggregate gross proceeds of $3,906,492. The financing included Commodity Discovery Fund (“CDF”) out of the Netherlands and was further bolstered by additional support from existing shareholders including funds managed by Sprott Asset Management LP and Crescat Capital. “We are incredibly happy to...

GRAND RAPIDS, Mich., July 12, 2021 (GLOBE NEWSWIRE) — Independent Bank Corporation (NASDAQ: IBCP), the holding company of Independent Bank, a Michigan-based community bank, announced that it expects to issue its 2021 second quarter results on Thursday, July 29, 2021, at approximately 8:00 am ET. The release will be available on the Internet at IndependentBank.com within the “News” section of the “Investor Relations” area of the Company’s website. Brad Kessel, President and CEO and Gavin Mohr, CFO will review the quarterly results in a conference call for investors and analysts beginning at 12:00 pm ET on Thursday, July 29, 2021. To participate in the live conference call, please dial 1-866-200-8394. Also the conference call will be accessible through an audio webcast with user-controlled slides via the following event site/URL:...

TULSA, OK, July 12, 2021 (GLOBE NEWSWIRE) — Laredo Petroleum, Inc., a Delaware corporation (NYSE: LPI) (“Laredo” or the “Company”), announced today that it intends, subject to market conditions, to offer $400 million in aggregate principal amount of senior unsecured notes due 2029 (the “notes”) in a private offering to eligible purchasers. The Company intends to use the net proceeds from the offering, if completed, for general corporate purposes, including, repaying a portion of the borrowings outstanding under the Company’s senior secured credit facility. The notes and the related guarantees to be offered have not and will not be registered under the Securities Act or any state securities laws and may not be offered or sold in the United States absent registration or an applicable exemption...

Figure 1Adumbi Deposit Longitudinal Section Looking Northeast with Drill Hole Grade (g/t) x True Thickness (Metre) Product ContoursFigure 2Geological Interpretation Surface Plan of the Adumbi DepositFigure 3Geological Cross Section A-BFigure 4Geological Cross Section C-D Highlighting Improved Grades of LADD0017 Infill HoleResults include 25.77 metres grading 6.24 g/t gold (including 9.29 metres grading 9.68 g/t gold and 5.50 metres grading 9.75 g/t gold), 17.15 metres grading 1.90 g/t gold and 13.45 metres grading 3.63 g/t goldTORONTO, July 12, 2021 (GLOBE NEWSWIRE) — Loncor Gold Inc. (“Loncor” or the “Company“) (TSX: “LN”; OTCQX: “LONCF”; FSE: “LO51”) is pleased to announce further significant assay results...

Medical Industry Veteran with Proven Track Record to Drive Commercialization Effort FRAMINGHAM, Mass., July 12, 2021 (GLOBE NEWSWIRE) — Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), developer of novel self-assembling wound care and biosurgical devices, today announced that Dan Yrigoyen has joined the organization as Vice President of Sales. Mr. Yrigoyen will lead the Company’s national commercialization effort with a focus on revenue generation and channel development. Mr. Yrigoyen has over 25 years of healthcare experience with a proven track record of driving business growth. Mr. Yrigoyen’s capabilities span a broad range of activities with expertise in the areas of new product launches, business process development, sales strategy, revenue generation and growth, metrics-driven performance management, and strategic...

DENVER and VANCOUVER, British Columbia, July 12, 2021 (GLOBE NEWSWIRE) — SPOTLITE360 TECHNOLOGIES, INC. (“Spotlite360” or the “Company”) (CSE: LITE) is pleased to announce that it has begun to commercialize its enterprise software solution in the healthcare industry to help overcome many of the common challenges in healthcare supply chains. In a press release dated July 6, 2021 the Company announced its pharmaceutical industry initiative to provide tracking, tracing, and sustainability solutions for stakeholders in the sourcing, production, transportation, and distribution of medications. With several operational and compliance nuances that are unique to healthcare supply chains, Spotlite360 has tailored its software solution which leverages blockchain, Internet-of-Things (“IoT”) sensors, and machine learning to align with the...

TORONTO, July 12, 2021 (GLOBE NEWSWIRE) — Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX:ASP, OTCQB:ASPCF) today announced that, on June 15, 2021, it prevailed at a preliminary issue trial in which Recipharm Limited (“Recipharm”) alleged that Acerus’ claim for damages was barred by the terms of the companies’ manufacturing contract. In agreeing with Acerus that its claim for damages was not barred, the Commercial Court of London directed the matter to proceed to a full trial in the coming months. Recipharm has asked for permission to appeal the court’s decision. “This is an important step forward in Acerus’ effort to hold Recipharm accountable for its contractual breaches,” said Ed Gudaitis, President and Chief Executive Officer of Acerus. “Manufacturers in the pharmaceutical industry rely on contract...

Medivolve closes $12M in funding needed to support strategic plan including next phase of growth for AI technology platform that will change the face of human health management. THIS NEWS RELEASE IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, July 12, 2021 (GLOBE NEWSWIRE) —  Medivolve Inc. (“Medivolve” or the “Company”)(NEO:MEDV; FRA:34C1), a healthcare technology and services company that seeks out disruptive technologies, ground-breaking innovations, and exclusive partnerships to transform human health management, is pleased to announce that the Company has closed the previously announced private placement of an aggregate of 171,428,571 units (the “Units”) at a price per Unit of $0.07 (the “Issue Price”) for aggregate gross proceeds to the Company of $12,000,000...